IP Library › Granted Patent US 12,522,698
Granted Patent B2
US 12,522,698 · App. 17/836,571 · Granted Jan 13, 2026

Processes and systems for preparing cellular or viral membranes and nanoparticles

Inventors: Weiwei Gao (La Jolla, CA); Che-Ming Jack Hu (Taipei, TW)
Assignee: Arytha Biosciences, LLC
C08J3/12C12N5/0006C12N5/0087C12N5/0641B01D2315/16B82Y40/00C08J2367/04C08J2377/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,522,698
App. No.
17/836,571
Granted
Jan 13, 2026
Kind
B2
Abstract

The present invention relates to processes and systems for preparing nanoparticles, cellular or viral membranes and/or cellular or viral membrane coated nanoparticles using or comprising, inter alia, a multi-inlet vortexing reactor, tangential flow filtration (TFF) and/or a high shear fluid processor such as a microfluidizer (or a microfluidizer processor). The present invention also relates to the nanoparticles, cellular or viral membranes and/or cellular or viral membrane coated nanoparticles prepared by the present processes and systems, and the uses and/or applications of the nanoparticles, cellular or viral membranes and/or cellular or viral membrane coated nanoparticles.

Claims (24)

1 . A process for preparing a nanoparticle, which process comprises:

1) mixing a polymer for forming a nanoparticle in an organic solvent and an aqueous phase comprising water or a water-based buffer using a multi-inlet vortexing reactor to form a composition comprising said nanoparticle wherein said organic solvent dissolves said polymer and is miscible with water; and

2) subjecting said composition to tangential flow filtration (TFF) to remove said organic solvent from said composition.

2 . The process of claim 1 , wherein the polymer is poly(lactic-co-glycolic acid) (PLGA).

3 . The process of claim 1 , wherein the polymer is selected from the group consisting of poly(lactic-co-glycolic acid) (PLGA), polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polylysine, polyglutamic acid and a hydrophobic polymer that coils when switched from an organic solvent to an aqueous phase.

4 . The process of claim 1 , wherein the polymer has a level ranging from about 0.01 mg/mL to about 40 mg/mL in the multi-inlet vortexing reactor in step 1).

5 . The process of claim 1 , wherein the organic solvent is acetonitrile or acetone.

6 . The process of claim 1 , wherein the organic solvent has a level ranging from about 1% (v/v) to about 50% (v/v) in the multi-inlet vortexing reactor in step 1).

7 . The process of claim 1 , wherein the multi-inlet vortexing reactor comprises a reaction chamber and multiple tangentially arranged inlets, through which the material for forming a nanoparticle in an organic solvent and/or an aqueous phase are injected into the reaction chamber.

8 . The process of claim 1 , wherein the organic solvent phase has a flow rate ranging from about 1 mL/minute to about 1,000 mL/minute in the multi-inlet vortexing reactor in step 1).

9 . The process of claim 1 , wherein the aqueous phase has a flow rate ranging from about 1 mL/minute to about 1,000 mL/minute in the multi-inlet vortexing reactor in step 1).

10 . The process of claim 1 , wherein step 1) and/or 2) are conducted at a temperature ranging from about 0° C. to about 40° C.

11 . The process of claim 1 , wherein the nanoparticle has a hydrodynamic size or diameter from about 10 nm to about 10 μm.

12 . The process of claim 1 , wherein the nanoparticle has a polydispersity index (PDI) from about 0.1 to about 0.7.

13 . The process of claim 1 , wherein the TFF is conducted using a TFF system that comprises a feed reservoir, a filter device and a collection device, the feed reservoir is in fluid communication with the filter device via an inlet on the filter device, the filter device is in fluid communication with the collection device via a permeate outlet on the filter device, and the filter device is in fluid communication with the feed reservoir via a retentate outlet on the filter device.

14 . The process of claim 1 , wherein the TFF is conducted via a diafiltration process.

15 . The process of claim 1 , wherein the TFF is conducted using a feeding rate ranging from about 0.1 mL/minute to about 1,000 mL/minute.

16 . The process of claim 1 , wherein the TFF is conducted using a feeding pressure ranging from about 0.1 psi to about 100 psi.

17 . The process of claim 1 , wherein the TFF is conducted using a retentate pressure ranging from about 0.1 psi to about 100 psi.

18 . The process of claim 1 , wherein the TFF is conducted within a time ranging from about 10 minutes to about 10 hours.

19 . The process of claim 1 , wherein:

the TFF is used to remove from about 50% to about 99.9999% of the organic solvent from the composition, or

the TFF is used to concentrate and/or enrich the nanoparticle from about 1 fold to about 100 fold.

20 . The process of claim 1 , which is used to prepare the nanoparticle at a production rate ranging from about 0.1 g/hour to about 1,000 g/hour for one production batch.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: GAO, WEIWEI; HU, CHE-MING JACK
To: ARYTHA BIOSCIENCES, LLC
Reel/Frame 060205/0449 →
Continuity (3)
Division 15777208
Provisional Application 62257161 · Nov 18, 2015
Related Publication 20220380556A1 · Dec 1, 2022
References Cited (40)
US 5490937A · van Reis · 1996 [cited by applicant]
US 8759294B2 · Egea et al. · 2014 [cited by applicant]
US 8889103B2 · Hay et al. · 2014 [cited by applicant]
US 11359058B2 · Gao et al. · 2022 [cited by applicant]
US 20130037977A1 · Burke et al. · 2013 [cited by applicant]
US 20130337066A1 · Zhang et al. · 2013 [cited by applicant]
US 20140256818A1 · Leung et al. · 2014 [cited by applicant]
US 20150343332A1 · Boyd et al. · 2015 [cited by applicant]
US 20170000875A1 · Hu · 2017 [cited by applicant]
US 20220372234A1 · Gao et al. · 2022 [cited by applicant]
CN 103857387A · 2014 [cited by applicant]
CN 108699253A · 2022 [cited by applicant]
HK 1261375 · 2022 [cited by applicant]
WO 2013052167A2 · 2013 [cited by applicant]
Dalwadi, et al. (2005) “Comparison of Diafiltration and Tangential Flow Filtration for Purification of Nanoparticle Suspensions”, Pharmaceutical Research, 22(12): 2152-62. (Year: 2005). [cited by examiner]
U.S. Appl. No. 15/777,208; Restriction Requirement dated Jul. 8, 2020. [cited by applicant]
U.S. Appl. No. 15/777,208; Response to Restriction Requirement dated Nov. 9, 2020. [cited by applicant]
U.S. Appl. No. 15/777,208; Non-Final Office Action dated Dec. 10, 2020. [cited by applicant]
U.S. Appl. No. 15/777,208; Response to Non-Final Office Action dated May 10, 2021. [cited by applicant]
U.S. Appl. No. 15/777,208; Final Office Action dated Jul. 8, 2021. [cited by applicant]
U.S. Appl. No. 15/777,208; Response to the Final Office Action dated Jan. 6, 2022. [cited by applicant]
U.S. Appl. No. 15/777,208; Notice of Allowance dated Feb. 17, 2022. [cited by applicant]
U.S. Appl. No. 17/751,052; Restriction Requirement dated Dec. 27, 2024. [cited by applicant]
U.S. Appl. No. 17/751,052; Response to Restriction Requirement dated Feb. 24, 2025. [cited by applicant]
U.S. Appl. No. 17/751,052; Non-Final Office Action dated Mar. 18, 2025. [cited by applicant]
U.S. Appl. No. 17/751,052; Response to Non-Final Office Action dated Jun. 18, 2025. [cited by applicant]
U.S. Appl. No. 17/751,052; Notice of Allowance dated Jul. 15, 2025. [cited by applicant]
Response to 2nd Office Action for Chinese patent application CN201680078779.6, dated Jul. 27, 2021, 27 pages. [cited by applicant]
Supplemental Amendments to 2nd Office Action for Chinese patent application CN201680078779.6, dated Sep. 23, 2021, 26 pages. [cited by applicant]
2nd Supplemental Response to 2nd Office Action for Chinese patent application CN201680078779.6, dated Oct. 12, 2021, 26 pages. [cited by applicant]
Notice of Registration Procedures for Chinese patent application CN201680078779.6, dated Oct. 25, 2021, 2 pages. [cited by applicant]
Notice to Grant the Patent Right for Chinese patent application CN201680078779.6, dated Oct. 25, 2021, 2 pages. [cited by applicant]
Search Report for Chinese patent application CN201680078779.6, dated Jun. 15, 2020, 2 pages. [cited by applicant]
1st Office Action for Chinese patent application CN201680078779.6, dated Jun. 29, 2020, 10 pages with extra 6 pages of English language equivalent or summary. [cited by applicant]
International Search Report for international patent application PCT/US2016/062935 (WO2017087897), dated Feb. 6, 2017, 3 pages. [cited by applicant]
Written Opinion of the International Searching Authority for international patent application PCT/US2016/062935 (WO2017087897), dated Feb. 6, 2017, 6 pages. [cited by applicant]
International Preliminary Report on Patentability for international patent application PCT/US2016/062935 (WO2017087897), dated May 22, 2018, 7 pages. [cited by applicant]
Response to 1st Office Action for Chinese patent application CN2016800787796, dated Jan. 14, 2021, 31 pages. [cited by applicant]
Claim Amendments (marked-up version) in Response to 1st Office Action for Chinese patent application CN2016800787796, dated Jan. 14, 2021, 16 pages. [cited by applicant]
2nd Office Action for Chinese patent application CN201680078779.6, dated May 14, 2021, 3 pages with extra 5 pages of English language equivalent or summery. [cited by applicant]